Article info
Research letter
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
- Correspondence to Professor Aras Kadioglu, Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, Ronald Ross Building, University of Liverpool, 8 West Derby Street, Liverpool, L69 7BE, UK; A.Kadioglu{at}liv.ac.uk
Citation
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
Publication history
- Received August 1, 2016
- Revised November 25, 2016
- Accepted December 16, 2016
- First published March 6, 2017.
Online issue publication
September 01, 2022
Article Versions
- Previous version (5 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/